{"id":"https://openalex.org/W4362636809","doi":"https://doi.org/10.1158/1535-7163.22519540.v1","title":"Figure S5 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity","display_name":"Figure S5 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362636809","doi":"https://doi.org/10.1158/1535-7163.22519540.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22519540.v1","doi":"https://doi.org/10.1158/1535-7163.22519540.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519540.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Site-Specific_PEGylation_of_Anti-Mesothelin_Recombinant_Immunotoxins_Increases_Half-life_and_Antitumor_Activity/22519540/1/files/39982165.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Site-Specific_PEGylation_of_Anti-Mesothelin_Recombinant_Immunotoxins_Increases_Half-life_and_Antitumor_Activity/22519540/1/files/39982165.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069928382","display_name":"Zeliang Zheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeliang Zheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042339519","display_name":"Ryuhei Okada","orcid":"https://orcid.org/0000-0003-3589-5054","observed_orcids":["https://orcid.org/0000-0003-3589-5054"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryuhei Okada","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3589-5054","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090173640","display_name":"Hisataka Kobayashi","orcid":"https://orcid.org/0000-0003-1019-4112","observed_orcids":["https://orcid.org/0000-0003-1019-4112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hisataka Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075595526","display_name":"Tadanobu Nagaya","orcid":"https://orcid.org/0000-0002-0091-8343","observed_orcids":["https://orcid.org/0000-0002-0091-8343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadanobu Nagaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005008349","display_name":"Junxia Wei","orcid":"https://orcid.org/0009-0009-8366-4657","observed_orcids":["https://orcid.org/0009-0009-8366-4657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junxia Wei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Qi Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101398908","display_name":"Fred Lee","orcid":"https://orcid.org/0000-0003-1275-5497","observed_orcids":["https://orcid.org/0000-0003-1275-5497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fred Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002583441","display_name":"Tapan Kumar Bera","orcid":"https://orcid.org/0000-0002-8779-4004","observed_orcids":["https://orcid.org/0000-0002-8779-4004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan K. Bera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015906742","display_name":"Yun Liang Gao","orcid":"https://orcid.org/0000-0002-9898-5690","observed_orcids":["https://orcid.org/0000-0002-9898-5690","https://orcid.org/0000-0002-9694-0907","https://orcid.org/0000-0002-3012-0340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yun Gao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052483257","display_name":"William A. Kuhlman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Kuhlman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076748687","display_name":"Chin\u2010Hsien Tai","orcid":"https://orcid.org/0000-0003-4766-0535","observed_orcids":["https://orcid.org/0000-0003-4766-0535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chin-Hsien Tai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9223-0270","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/recombinant-immunotoxin","display_name":"recombinant immunotoxin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9729999899864197},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.6370000243186951},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9509999752044678},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.9369240999221802},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.8964194059371948},{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.8329986333847046},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.7248476147651672},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.5808766484260559},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.49895739555358887},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4879559874534607},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45881375670433044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40880101919174194},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3310048580169678},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24521702527999878},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19022303819656372},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1524207890033722},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.14890652894973755},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14397719502449036},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1015816330909729},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0817154049873352},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07112562656402588},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06528365612030029},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.056586772203445435},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22519540.v1","doi":"https://doi.org/10.1158/1535-7163.22519540.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519540.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Site-Specific_PEGylation_of_Anti-Mesothelin_Recombinant_Immunotoxins_Increases_Half-life_and_Antitumor_Activity/22519540/1/files/39982165.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22519540","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S5_from_Site-Specific_PEGylation_of_Anti-Mesothelin_Recombinant_Immunotoxins_Increases_Half-life_and_Antitumor_Activity/22519540","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22519540.v1","doi":"https://doi.org/10.1158/1535-7163.22519540.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519540.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S5_from_Site-Specific_PEGylation_of_Anti-Mesothelin_Recombinant_Immunotoxins_Increases_Half-life_and_Antitumor_Activity/22519540/1/files/39982165.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362636809.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362614229","https://openalex.org/W4362638274","https://openalex.org/W4362624793","https://openalex.org/W4362638121","https://openalex.org/W4362637515","https://openalex.org/W4392701640","https://openalex.org/W2997388109","https://openalex.org/W2020169547","https://openalex.org/W1990761369","https://openalex.org/W2175610656"],"abstract_inverted_index":{"Biodistribution":[0],"of":[1],"LMB-249-PEG":[2],"and":[3],"SS1P":[4]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-04-07T00:00:00"}